Meningitis Research Foundation to Present International Conference: Meningitis and Septicaemia in Children & Adults 2013

21 Aug 2013
Sarah Thomas
Associate Editor

Product news

International charity Meningitis Research Foundation is holding its 2 day conference on Meningitis and Septicaemia in Children and Adults on Tuesday 05 & Wednesday 06 November 2013 at the Royal Society of Medicine, London, UK.

For the ninth year, the conference will bring together internationally renowned experts from a range of specialties in the UK and abroad to address the most important issues of the day, including burden of illness, recognition and treatment, vaccine development, vaccine implementation and public health policy, and tackling meningitis in Africa.

Linda Glennie, Head of Research and Medical Information said “our conference attracts delegates from around the world and is a key event in the calendar for some of the foremost scientists and clinicians in the field of meningitis and septicaemia. It provides an excellent opportunity to discuss the latest developments and network with colleagues.”

• Plenary sessions over two days including panel debates and interactive sessions
• Poster presentations including oral presentations from the top 5 posters
• Satellite session sponsored by Novartis Vaccines and Diagnostics
• Evening wine reception

Speakers and organizers include: Dr Hareth Al-Janabi, Professor Ray Borrow, Dr Nicola Desmond, Professor Ian Feavers, Professor Adam Finn, Professor David Goldblatt, Professor Brian Greenwood, Professor George Griffin, Professor Paul Heath, Professor Nigel Klein, Dr Shamez Ladhani, Professor David Lalloo, Professor Michael Levin, Professor Martin Maiden, Dr Simon Nadel, Dr Ifeanyichukwu Okike, Professor Andrew Pollard, Dr Marie-Pierre Préziosi, Dr Mary Ramsay, Dr Karen Slobod, Dr Matthew Snape, Professor Christoph Tang, Dr Caroline Trotter

Links

Tags

Biopharmaceutical AdvancesBiopharmaceutical advances follow the development of pharmaceuticals derived from biotechnology, also known as biotechnology medicines. Biopharmaceuticals may be produced from cell lines, plants, or microbial cells. Important considerations of biopharmaceutical use include application, cost, production process and purification.Clinical MicrobiologyMicrobiology is the study of microorganisms including protists, prokaryotes, fungi, and, often, viruses. Microorganisms are a useful research tool as genetic vectors and, in immunology, for antibiotic susceptibility testing, cellular biology and genetics. Microorganisms commonly grow readily in incubators with microbial culture media; this can contain chromogenic supplements to differentiate between cell lines. Estimate your culture’s density of microorganisms with colony counters, or screen and select colonies for desirable clones with automated colony pickers. Additionally, equipment is available to monitor environments for the presence of microbes and identify with microbial identification instruments. Find the best microbiology products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Vaccine DevelopmentVaccine development focuses on creating immunizations to protect against infectious diseases. The process involves identifying antigens, developing and testing vaccine efficacy, and ensuring safety through preclinical testing and multiple clinical trial phases. Scientists use various approaches, including weakened or inactivated viruses, protein subunits, or mRNA. Advanced platforms and rapid diagnostic tools aid in vaccine research and testing. Explore vaccine development solutions in our peer-reviewed product directory; compare products, read reviews, and get pricing directly from manufacturers. Septicemia